Vertex Pharmaceuticals (NASDAQ:VRTX)

fda_logo

5 Critical Biotech Drug Dates and Events for December

At least five upcoming dates could be big days in December, for better or worse, for individual biotech stocks. These events refer to reviews and decisions by the U.S. Food ...
Read Full Story »
135093244

The Best Stocks of 2014 Part 1: Materials, Consumer, Health, Industrials

Stocks have enjoyed yet another wonderful year in 2014, and the bull market is now more than five and a half years old. With the S&P 500 index up almost ...
Read Full Story »
biotech

RBC Has Three Top Biotech Picks for Year End and 2015

If any sector has had an up and down 2014, it would be the biotech. A massive sell-off in the spring and in the fall has given some biotech investors ...
Read Full Story »
buy sell

Market Rally Brings Out Insider Sellers in Full Force

Less than a month ago, insider selling was just at a trickle, and it was clear that most insiders had no interest in selling into a market that was one ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Cliffs, CME, Darden, Endo, J.C. Penney and More

Stocks were firm on Monday morning after a weak Thursday and Friday, and the question is how much Columbus Day will matter for the markets. So far, we have seen ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: Apple, Alcobra, Deere, GT, J.C. Penney and More

Stocks were weak on Tuesday, but investors keep proving that they will aggressively buy overlooked or oversold stocks when they can. 24/7 Wall St. reviews dozens of brokerage firm analyst ...
Read Full Story »
Biotechnology word cloud

5 Orphan Drug Biotech Stocks to Buy With Big Upside Potential

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition. In the United States and the European Union, it is easier to ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: BP, Ciena, Finisar, SanDisk, VeriFone, Vertex, Wynn and More

Stocks were soft on Friday ahead of the unemployment report. Still, the markets are effectively around all-time highs, and investors remain optimistic about the U.S. recovery and are looking for ...
Read Full Story »
biotech

5 Huge Biotech Catalysts Right Around the Corner for Top Stocks

A brand new research report from RBC highlights more than 50 biotech event catalysts that are on the horizon. These are trial data, FDA decisions and company presentations coming soon. The ...
Read Full Story »
Biotechnology word cloud

UBS Very Bullish on Biotech Stocks Ahead of Second-Quarter Earnings

After the biotech stocks were absolutely crushed in the late winter and early spring, many of the top firms we cover on Wall Street were aggressive in their calls to ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Abengoa Yield, CSC, Groupon, 3M, Vertex, Williams, Xerox and More

Stocks were lower again on Tuesday ahead of the unofficial launch of earnings season and after the DJIA 17,000 milestone was hit for the first time ever last week. Now ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Apple, Coach, J.C. Penney, Micron, Whole Foods, Vertex and More

It is Wednesday and stocks are trying to find their footing in mixed markets after a fresh sell-off. Investors and traders are getting used to hearing that the raging bull ...
Read Full Story »
biotech

The Real Attraction to Vertex After Cystic Fibrosis Success

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) reported Tuesday morning that two Phase 3 studies of the company's lumacaftor cystic fibrosis drug in combination with its Kalydeco ivacaftor drug showed statistically significant ...
Read Full Story »
Pills

Upcoming Binary Events Could Lift These Health Care Stocks Much Higher

Binary events in the health care arena can be huge in determining just how well investors do and their stocks perform. Medical meetings, clinical data and of, course, decisions by ...
Read Full Story »
Biotechnology word cloud

After Idenix: The Next Four Biotech Buyout Candidates

Wall Street likes nothing better than to start the week off with a bang, and pharmaceutical giant Merck & Co. Inc. (NYSE: MRK) rang the bell Monday by spending $3.85 ...
Read Full Story »